Each level tsp (2.9 g) serving contains: Inosine 2.9 g.
Brand name products often contain multiple ingredients. To read detailed information about each ingredient, click on the link for the individual ingredient shown above.
Below is general information about the effectiveness of the known ingredients contained in the product Inosine Powder. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product Inosine Powder. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
POSSIBLY SAFE ...when used orally and appropriately. Inosine has been used with apparent safety at doses of up to 3 grams daily for up to 24 months or at doses of up to 2 grams daily for 36 months (95287,95289,95290,95291,106854,106857,112396).
PREGNANCY AND LACTATION:
Insufficient reliable information available; avoid using.
Below is general information about the interactions of the known ingredients contained in the product Inosine Powder. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Inosine might reduce the effects of antigout medications.
Details
|
Below is general information about the adverse effects of the known ingredients contained in the product Inosine Powder. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General
...Orally, inosine seems to be well tolerated.
Most Common Adverse Effects:
Orally: Hyperuricemia, nephrolithiasis, uric acid crystals, urinary tract stones.
Serious Adverse Effects (Rare):
Orally: Hypertension, kidney dysfunction.
Cardiovascular ...Orally, inosine was reported to cause mild elevation of blood pressure in 6% of patients in one clinical trial (95289).
Endocrine ...Orally, inosine increases serum uric acid levels in a dose-dependent manner, which can cause non-symptomatic hyperuricemia (95288,95289).
Gastrointestinal ...Orally, inosine has been reported to cause nausea (95289,106854).
Genitourinary ...Orally, inosine has been reported to cause uric acid crystals and symptomatic uric acid kidney stones. Uric acid kidney stones occurred more frequently when inosine was taken concurrently with calcium supplements (95287,95289,95290,106854,112395).
Renal ...Orally, inosine 1-2 grams daily has been reported to cause acute renal colic in patients with multiple sclerosis (95288). Inosine has also been reported to cause reversible reductions in kidney function (106854).